Two Russia New Coronavirus Vaccines are Registered!

Several vaccines developed in Europe and the United States have repeatedly encountered problems in the third phase of trials, and the trials have to be suspended. In addition to the cooperation between AstraZeneca and Oxford University, the vaccine developed by Johnson & Johnson in the United States also announced a suspension of testing recently. Trump was a little anxious when he lost two vaccines with high hopes. Once again, he turned his attention to 'special medicine' and antibody therapy, and announced that all Americans can receive 'antibody cocktail therapy' treatment for free.
 

Just as the United States was anxious to find alternative medicines, Russia once again spread news that the country has already registered two new coronavirus vaccines! According to media reports, Putin announced a few days ago that Russia has successfully registered the second domestically-made new coronavirus vaccine, and soon the third vaccine will be put into use. Russia will further increase the output of the first and second vaccines and promote them abroad. The rapid progress of Russian vaccines has shocked the outside world. Currently, there are only two registered vaccines in the world, both from Russia. After Russia registered its first vaccine 'Sputnik-V' in August, it has been questioned by the outside world because it has not passed the third phase of clinical trials. American experts even claimed that the vaccine might have safety issues, which made the Russians hesitate.
 

In September, the 'Sputnik-v' vaccine carried out the third phase of clinical trials. The latest results showed that 14% of vaccinators had mild adverse reactions, including fever, fatigue, etc., but these were written on the instructions and belonged to the normal range. Subsequently, many countries threw an 'olive branch' to Russia, and they have won at least one billion intent orders. The newly registered vaccine also did not undergo the third round of trials, and only 100 people participated in the trial from beginning to end, and there were no obvious adverse symptoms. The vaccine is developed by a biological center in Siberia. The third round of trials will be launched in November, when 40,000 volunteers will participate. The reason why Russia is so anxious to launch vaccines is not only its confidence in technology, but also its desire to seize more overseas markets, which is a good opportunity to boost the economy.
 

Seeing that Russia is so positive, the United States can't sit still. As the epicenter of the epidemic, the United States has a total of 8.21 million confirmed cases and more than 222,000 deaths; controlling the epidemic is an urgent matter for the United States. Many American media said that they can only give it a go! Vaccines went wrong one after another, and we can only count on 'antibody cocktail therapy'. Although the trial has not yet ended, Regeneron has applied for emergency approval from the FDA. However, just a few days ago, Eli Lilly and Co The trial has been suspended for safety reasons, that is to say, the therapy still has risks. After all, not every American can enjoy presidential treatment!
 

Disclaimer